Warner Bros tells shareholders to reject £80bn Paramount bid
Warner Bros Discovery urges investors to reject a sweetened $108bn hostile bid from Paramount Skydance, favouring a Netflix merger. The board cites regulatory risks and insufficient value.
Warner Bros Discovery urges investors to reject a sweetened $108bn hostile bid from Paramount Skydance, favouring a Netflix merger. The board cites regulatory risks and insufficient value.
A senior Trump official says a stark US warning about Europe's 'civilisational erasure' was meant to jolt the ally into pro-growth reforms. Read the full story on the transatlantic rift.
A senior Trump official insists a US strategy warning of Europe's 'civilisational erasure' was meant as a 'jolt' to spur pro-growth reforms and counter economic decline. Read the full analysis.
A stark new survey reveals deep pessimism among UK family businesses, with most viewing the 1970s as a better era for tax and regulation. Read the full report on the growing disconnect with government.
Loose Women star Nadia Sawalha shares grief after friend Hannah Gardner, 39, dies from breast cancer. They campaigned for NHS to approve life-extending drug Enhertu, available in Scotland but not England.
Donald Trump ends his first year back in the White House with a record-low 36% approval rating, matching his own previous low. Discover the key factors behind the slump.
Exclusive Deltapoll puts Reform UK ahead at 30%, with Labour on 20% and Tories on 19%. PM Keir Starmer faces a stark warning from voters ahead of crucial 2026 elections. Read the full analysis.
President Donald Trump attempted to sell his economic record at a North Carolina rally en route to Mar-a-Lago, but new polls show deep voter dissatisfaction with his management. Read the full analysis.
Donald Trump defended his economic record at a North Carolina rally before his Mar-a-Lago vacation, ignoring the Epstein files release. New polls show his approval at a second-term low. Read the full analysis.
A new Quinnipiac University survey reveals most American voters believe President Donald Trump has gone too far in wielding executive power, with key disapproval on economy and immigration. Read the full analysis.
President Trump used a televised address to blame predecessor Joe Biden for economic struggles, offering few new plans. New polls show 57% disapprove of his economic management.
US regulators approve two new antibiotics, zoliflodacin and gepotidacin, offering hope in the fight against drug-resistant gonorrhoea as global cases surge. A potential turning point for global health.
US health officials approve Addyi for women over 65 with low sexual desire. Learn about the decade-long journey, side effects, and the debate surrounding female sexual health treatments.
Donald Trump's approval rating climbs two points to 47% amid falling gas prices and record holiday spending, though 53% still disapprove. Discover the full poll analysis.
A new CBS/YouGov poll reveals President Trump's approval with voters aged 18-29 has crashed from +10 to -46. Analysis points to policy concerns and waning influencer backing. Read the full breakdown.
A pivotal 2000 scientific paper used globally to defend glyphosate's safety has been retracted due to evidence of Monsanto's influence and ghostwriting. Read the full investigation.
Plans for a £450m Center Parcs near Hawick have been recommended for approval, promising 700 lodges and a major economic boost. The final decision is due on 8 December.
Planning officials recommend approval for Scotland's first £450m Center Parcs near Hawick. The 'transformational' project, opening in 2029, promises 700 lodges and major economic benefits for the Borders.
A groundbreaking rectal cancer treatment called Papillon, which uses low-energy X-rays, has been approved for NHS use. This offers patients a chance to avoid major surgery and stomas, improving quality of life.
A new YouGov survey reveals nearly 50% of US adults believe Donald Trump will be remembered as a 'poor' or 'below average' president, as his approval ratings hit record lows. Read the full analysis.
Insiders report President Trump has scaled back public rallies, becoming isolated in a pro-Trump media bubble. Allies worry he's out of touch with voters who elected him. Read the full analysis.
FDA's Dr Vinay Prasad announces stricter vaccine approval process following claims Covid vaccines killed children. Experts call move 'dangerous' as it may slow vaccine pipeline and upend established immunisation guidance.
Exclusive poll reveals American voters' top concern is the rising cost of living, not Trump's tech deals. Discover why affordability threatens his second term and the 2026 elections.
New Pew Research shows overwhelming Latino disapproval of Trump's presidency, with 70% criticising his job performance and policies. Discover the shifting political landscape.
A groundbreaking 'next generation' immunotherapy treatment offering hope to leukaemia patients receives NHS approval after clinical trials showed 77% remission rates. Discover this medical breakthrough.
A groundbreaking 'next generation' CAR T-cell therapy for leukaemia, developed in the UK, has been approved for NHS use. This one-time treatment offers new hope with high remission rates. Discover how this medical breakthrough could save lives.
Chancellor Rachel Reeves faces a crucial Budget with record low approval ratings. Pollster warns she is 'losing the room' with voters on the economy and public services.
Exclusive polling reveals Donald Trump's approval rating has hit a new low, dropping 10 points in two months. Voters cite his economic and immigration policies as key reasons for the decline. Discover the full analysis.
New polling reveals 67% of Britons want Rachel Reeves to cut government spending rather than increase taxes in this week's crucial Budget. Discover the public's verdict on Labour's economic leadership.
Merivale boss Justin Hemmes presses on with Byron Bay venue expansion despite recent council fine. Discover the latest developments and local reactions to this controversial project.